Cargando…
Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone
Resistance to chemotherapy is a major obstacle to the effective treatment of many tumor types. Although many anticancer therapies can alter tumor growth, in most cases the effect is not long lasting. Consequently, there is a significant need for new agents with low susceptibility to common drug resi...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972556/ https://www.ncbi.nlm.nih.gov/pubmed/21050423 http://dx.doi.org/10.1186/bcr2573 |